Wczytywanie spółki
Just reported
Q3 2026 results
From P3 Health Partners's results release of 9 listopada 2026; its quarterly report has since been filed.
Revenue
Actual
396,3M USD
+15% y/y
+2,6% q/qGuided
—
No guide given
EPS, GAAP
Actual
0,07 USD
-97% q/q
Guided
—
No guide given
Operating income, GAAP
Actual
23M USD
-44% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes P3 Health Partners is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B USDA+
EHCEncompass Health Corporation13,8B USDA+
ENSGEnsign Group, Inc.11B USDA
PACSPACS Group, Inc.7,7B USDA
CONConcentra Group Holdings Parent, Inc.5,4B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 paź 2026CAGraded C, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki P3 Health Partners Inc. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
